CJC-1295 DAC (5mg)

CJC-1295 DAC is a research-grade peptide studied for its long-lasting stimulation of growth hormone (GH) via the GHRH receptor (Growth Hormone Releasing Hormone).

Thanks to the addition of DAC (Drug Affinity Complex), the peptide binds to serum albumin, significantly extending its half-life compared to CJC-1295 without DAC.

This unique property makes CJC-1295 DAC especially relevant for research into hormone regulation, IGF-1 dynamics, metabolism, recovery processes, and energy balance.

Research findings:
Preclinical and clinical studies show that CJC-1295 DAC:
• Increases the amplitude and duration of GH pulses
• Leads to a prolonged elevated IGF-1 level
• Maintains continuous GHRH activation due to its long duration of action

Researchers study CJC-1295 DAC in relation to body composition, anabolic signaling, tissue repair, and age-related hormonal changes. Additional studies focus on long-term safety and endocrine effects of prolonged GHRH receptor stimulation.

Research context:
Used in laboratories and research institutions to analyze:
• Long-acting GHRH analogs
• Growth hormone pulsation and regulation
• IGF-1 mediated metabolic pathways
• Endocrine and anabolic signaling mechanisms

Often used as a reference standard in hormonal and metabolic research models.

Important information:
• For laboratory research only
• Not intended for human consumption or injection
• Research & development use only
• Buyer responsible for compliance with local laws
• Seller not liable for improper use

Comparison: CJC-1295 DAC vs Non-DAC
• Half-life: Very long (days) vs Short (minutes/hours)
• Duration: Continuous & long vs Short & pulsatile
• GH stimulation: Sustained vs Temporary
• IGF-1 increase: Prolonged vs Short-lived
• Research focus: Long-term GH regulation vs Acute GH pulses
• Research application: Less frequent vs More frequent